X

Trial Profile

A phase I multiple ascending dose study to assess the safety, tolerability, and pharmacokinetic profile of HPP737 in healthy volunteers

Status: Active, no longer recruiting

Phase of Trial: Phase I

Latest Information Update: 30 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs HPP 737 (Primary)
Indications Chronic obstructive pulmonary disease; Psoriasis
Focus Adverse reactions
Sponsors vTv Therapeutics LLC

Most Recent Events

23 Sep 2021 Results presented in a vTv Therapeutics media release.
04 Aug 2021 Status changed from recruiting to active, no longer recruiting, according to a vTv Therapeutics media release.
04 Aug 2021 According to a vTv Therapeutics media release, the company has completed the dosing the healthy subjects in this study.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com